Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroblastoma × Immunotherapy × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Esophageal Neoplasms 7 Colorectal Neoplasms 6 Melanoma 4 Lung Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Unresectable Biliary Tract Cancer 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Small Cell Lung Cancer Extensive Stage 1 Sarcopenia 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Neuroblastoma 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Muscle-Invasive Bladder Carcinoma 1

Interventions

Temozolomide 13 Irinotecan 10 Cyclophosphamide 8 naxitamab 7 dinutuximab 6 sargramostim 5 Vincristine 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Melphalan 4 Carboplatin 4 fludarabine 3 Zoledronic Acid 3 Etoposide 3 Eflornithine 3 Doxorubicin 3 saponin QA-21V1 2 lutetium Lu 177 dotatate 2 etoposide phosphate 2 aldesleukin 2 Topotecan 2 Thiotepa 2 Specimen Handling 2 Interleukin-2 2 Granulocyte Colony-Stimulating Factor 2 Colony-Stimulating Factors 2 Cisplatin 2 Busulfan 2 3-fluorobenzylguanidine 2 3-Iodobenzylguanidine 2 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06485947 2025-07-08

DBPilot

Princess Maxima Center for Pediatric Oncology

Phase 1 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡